This work is licensed under the Creative Commons Attribution 4.0 International License.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021; 71: 7–33. doi: 10.3322/caac.21654SiegelRLMillerKDFuchsHEJemalACancer statistics, 202120217173310.3322/caac.21654Open DOISearch in Google Scholar
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144: 1941–53. doi: 10.1002/ijc.31937FerlayJColombetMSoerjomataramIMathersCParkinDMPinerosMEstimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods201914419415310.1002/ijc.31937Open DOISearch in Google Scholar
Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2023; 34: 339–57. doi: 10.1016/j.annonc.2022.12.009HendriksLEKerrKMMenisJMokTSNestleUPassaroAOncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up2023343395710.1016/j.annonc.2022.12.009Open DOISearch in Google Scholar
Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2023; 34: 358–76. doi: 10.1016/j.annonc.2022.12.013HendriksLEKerrKMMenisJMokTSNestleUPassaroANon-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up2023343587610.1016/j.annonc.2022.12.013Open DOISearch in Google Scholar
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108. doi: 10.3322/caac.21262TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 20122015658710810.3322/caac.21262Open DOISearch in Google Scholar
Murray PV, O’Brien ME, Sayer R, Cooke N, Knowles G, Miller AC, et al. The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway. Lung Cancer 2003; 42: 283–90. doi: 10.1016/s0169-5002(03)00358-1MurrayPVO’BrienMESayerRCookeNKnowlesGMillerACThe pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway2003422839010.1016/s0169-5002(03)00358-1Open DOISearch in Google Scholar
Copeland J, Neal E, Phillips W, Hofferberth S, Lathan C, Donington J, et al. Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model. MethodsX 2023; 11: 102338. doi: 10.1016/j.mex.2023.102338CopelandJNealEPhillipsWHofferberthSLathanCDoningtonJRestructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model20231110233810.1016/j.mex.2023.102338Open DOISearch in Google Scholar
Dunn J, Garvey G, Valery PC, Ball D, Fong KM, Vinod S, et al. Barriers to lung cancer care: health professionals’ perspectives. Support Care Cancer 2017; 25: 497–504. doi: 10.1007/s00520-016-3428-3DunnJGarveyGValeryPCBallDFongKMVinodSBarriers to lung cancer care: health professionals’ perspectives20172549750410.1007/s00520-016-3428-3Open DOISearch in Google Scholar
Kutubudin F, Robinson R, Deus P, Hughes K, Wight AG. Impact of national optimal lung cancer pathway – can we meet the 28 day standard by 2020? [abstract]. Thorax 2018; 73(Suppl 4): A140. doi: 10.1136/thorax-2018-212555.229KutubudinFRobinsonRDeusPHughesKWightAGImpact of national optimal lung cancer pathway – can we meet the 28 day standard by 2020? [abstract]201873Suppl 4A14010.1136/thorax-2018-212555.229Open DOISearch in Google Scholar
Jaly A, Conroy S, Mohsin N. Implementing the National Optimal Lung Cancer Pathway; STHK experience. European Congress of Radiology - ECR 2020; Poster: C-12308. [Internet]. Available at: https://dx.doi.org/10.26044/ecr2020/C-12308. doi: 10.26044/ecr2020/C-12308JalyAConroySMohsinNEuropean Congress of Radiology - ECR2020Poster: C-12308. [Internet]. Available at: https://dx.doi.org/10.26044/ecr2020/C-12308.10.26044/ecr2020/C-12308Open DOISearch in Google Scholar
Fung-Kee-Fung M, Maziak DE, Pantarotto JR, Smylie J, Taylor L, Timlin T, et al. Regional process redesign of lung cancer care: a learning health system pilot project. Curr Oncol 2018; 25: 59–66. doi: 10.3747/co.25.3719Fung-Kee-FungMMaziakDEPantarottoJRSmylieJTaylorLTimlinTRegional process redesign of lung cancer care: a learning health system pilot project201825596610.3747/co.25.3719Open DOISearch in Google Scholar
Jacobsen MM, Silverstein SC, Quinn M, Waterston LB, Thomas CA, Benneyan JC, et al. Timeliness of access to lung cancer diagnosis and treatment: a scoping literature review. Lung Cancer 2017; 112: 156–64. doi: 10.1016/j.lungcan.2017.08.011JacobsenMMSilversteinSCQuinnMWaterstonLBThomasCABenneyanJCTimeliness of access to lung cancer diagnosis and treatment: a scoping literature review20171121566410.1016/j.lungcan.2017.08.011Open DOISearch in Google Scholar
Rankin NM, York S, Stone E, Barnes D, McGregor D, Lai M, et al. Pathways to lung cancer diagnosis: a qualitative study of patients and general practitioners about diagnostic and pretreatment intervals. Ann Am Thorac Soc 2017; 14: 742–53. doi: 10.1513/AnnalsATS.201610-817OCRankinNMYorkSStoneEBarnesDMcGregorDLaiMPathways to lung cancer diagnosis: a qualitative study of patients and general practitioners about diagnostic and pretreatment intervals2017147425310.1513/AnnalsATS.201610-817OCOpen DOISearch in Google Scholar
Ost DE, Yeung SCJ, Tanoue LT, Gould MK. Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143(5 Suppl): e121S–41S. doi: 10.1378/chest.12-2352OstDEYeungSCJTanoueLTGouldMKClinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines20131435 Supple121S41S10.1378/chest.12-2352Open DOISearch in Google Scholar
Kanashiki M, Satoh H, Ishikawa H, Yamashita YT, Ohtsuka M, Sekizawa K. Time from finding abnormality on mass-screening to final diagnosis of lung cancer. Oncol Rep 2003; 10: 649–52. doi: 10.3892/or.10.3.649KanashikiMSatohHIshikawaHYamashitaYTOhtsukaMSekizawaKTime from finding abnormality on mass-screening to final diagnosis of lung cancer2003106495210.3892/or.10.3.649Open DOISearch in Google Scholar
Kashiwabara K, Koshi S, Itonaga K, Nakahara O, Tanaka M, Toyonaga M. Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor. Lung Cancer 2003; 40: 67–72. doi: 10.1016/s0169-5002(02)00505-6KashiwabaraKKoshiSItonagaKNakaharaOTanakaMToyonagaMOutcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor200340677210.1016/s0169-5002(02)00505-6Open DOISearch in Google Scholar
Salomaa ER, Sallinen S, Hiekkanen H, Liippo K. Delays in the diagnosis and treatment of lung cancer. Chest 2005; 128: 2282–8. doi: 10.1378/chest.128.4.2282SalomaaERSallinenSHiekkanenHLiippoKDelays in the diagnosis and treatment of lung cancer20051282282810.1378/chest.128.4.2282Open DOISearch in Google Scholar
Saint-Jacques N, Rayson D, Al-Fayea T, Virik K, Morzycki W, Younis T. Waiting times in early-stage non-small cell lung cancer (NSCLC). J Thorac Oncol 2008; 3: 865–70. doi: 10.1097/JTO.0b013e318180210cSaint-JacquesNRaysonDAl-FayeaTVirikKMorzyckiWYounisTWaiting times in early-stage non-small cell lung cancer (NSCLC)200838657010.1097/JTO.0b013e318180210cOpen DOISearch in Google Scholar
Risberg T, Sorbye SW, Norum J, Wist EA. Diagnostic delay causes more psychological distress in female than in male cancer patients. Anticancer Res 1996; 16: 995–9. PMID: 8687166.RisbergTSorbyeSWNorumJWistEADiagnostic delay causes more psychological distress in female than in male cancer patients19961699598687166Search in Google Scholar
Malalasekera A, Nahm S, Blinman PL, Kao SC, Dhillon HM, Vardy JL. How long is too long? A scoping review of health system delays in lung cancer. Eur Respir Rev 2018; 27: 180045. doi: 10.1183/16000617.0045-2018MalalasekeraANahmSBlinmanPLKaoSCDhillonHMVardyJLHow long is too long? A scoping review of health system delays in lung cancer20182718004510.1183/16000617.0045-2018Open DOISearch in Google Scholar
Neal RD, Robbe IJ, Lewis M, Williamson I, Hanson J. The complexity and difficulty of diagnosing lung cancer: findings from a national primary-care study in Wales. Prim Health Care Res Dev 2015; 16: 436–49. doi: 10.1017/S1463423614000516NealRDRobbeIJLewisMWilliamsonIHansonJThe complexity and difficulty of diagnosing lung cancer: findings from a national primary-care study in Wales2015164364910.1017/S1463423614000516Open DOISearch in Google Scholar
Al Achkar M, Zigman Suchsland M, Walter FM, Neal RD, Goulart BHL, Thompson MJ. Experiences along the diagnostic pathway for patients with advanced lung cancer in the USA: a qualitative study. BMJ Open 2021; 11: e045056. doi: 10.1136/bmjopen-2020-045056Al AchkarMZigman SuchslandMWalterFMNealRDGoulartBHLThompsonMJExperiences along the diagnostic pathway for patients with advanced lung cancer in the USA: a qualitative study202111e04505610.1136/bmjopen-2020-045056Open DOISearch in Google Scholar
White V, Bergin RJ, Thomas RJ, Whitfield K, Weller D. The pathway to diagnosis and treatment for surgically managed lung cancer patients. Fam Pract 2020; 37: 234–41. doi: 10.1093/fampra/cmz064.zWhiteVBerginRJThomasRJWhitfieldKWellerDThe pathway to diagnosis and treatment for surgically managed lung cancer patients2020372344110.1093/fampra/cmz064.zOpen DOISearch in Google Scholar
Dunican E, Uzbeck M, Clince J, Toner S, Royston D, Logan MP, et al. Outcomes of patients presenting to a dedicated rapid access lung cancer clinic. Ir Med J 2011; 104: 265–8. PMID: 22132593DunicanEUzbeckMClinceJTonerSRoystonDLoganMPOutcomes of patients presenting to a dedicated rapid access lung cancer clinic2011104265822132593Search in Google Scholar
Aasebo U, Strom HH, Postmyr M. The Lean method as a clinical pathway facilitator in patients with lung cancer. Clin Respir J 2012; 6:169–74. doi: 10.1111/j.1752-699X.2011.00271.xAaseboUStromHHPostmyrMThe Lean method as a clinical pathway facilitator in patients with lung cancer201261697410.1111/j.1752-699X.2011.00271.xOpen DOISearch in Google Scholar
Hueto Pérez De Heredia J, Cebollero Rivas P, Cascante Rodrigo JA, Andrade Vela I, Pascal Martínez I, Boldú Mitjans J, et al. Evaluation of the use of a rapid diagnostic consultation of lung cancer. Delay time of diagnosis and therapy. Arch Bronconeumol 2012; 48: 267–73. doi: 10.1016/j.arbr.2012.06.003Hueto Pérez De HerediaJCebollero RivasPCascante RodrigoJAAndrade VelaIPascal MartínezIBoldú MitjansJEvaluation of the use of a rapid diagnostic consultation of lung cancer. Delay time of diagnosis and therapy2012482677310.1016/j.arbr.2012.06.003Open DOISearch in Google Scholar
Lo DS, Zeldin RA, Skrastins R, Fraser IM, Newman H, Monavvari A, et al. Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis. J Thorac Oncol 2007; 2: 1001–6. doi: 10.1097/JTO.0b013e318158d4b6LoDSZeldinRASkrastinsRFraserIMNewmanHMonavvariATime to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis200721001610.1097/JTO.0b013e318158d4b6Open DOISearch in Google Scholar
Murphy DR, Wu L, Thomas EJ, Forjuoh SN, Meyer AN, Singh H. Electronic trigger-based intervention to reduce delays in diagnostic evaluation for cancer: a cluster randomized controlled trial. J Clin Oncol 2015; 33: 3560–7. doi: 10.1200/JCO.2015.61.1301MurphyDRWuLThomasEJForjuohSNMeyerANSinghHElectronic trigger-based intervention to reduce delays in diagnostic evaluation for cancer: a cluster randomized controlled trial2015333560710.1200/JCO.2015.61.1301Open DOISearch in Google Scholar
Triller N, Bereš V, Rozman A. [Delays in the diagnosis and treatment of lung cancer: can the period between the onset of symptoms and the diagnosis and treatment be shortened?] [Slovenian]. [Internet]. Zdrav Vestn 2010; 79: 618–22. [cited 2020 Jan 10]. Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/287TrillerNBerešVRozmanA[Delays in the diagnosis and treatment of lung cancer: can the period between the onset of symptoms and the diagnosis and treatment be shortened?] [Slovenian]. [Internet]20107961822[cited 2020 Jan 10]. Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/287Search in Google Scholar
Aapro M, Bossi P, Dasari A, Fallowfield L, Gascon P, Geller M, et al. Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Support Care Cancer 2020; 28: 4589–12. doi: 10.1007/s00520-020-05539-1AaproMBossiPDasariAFallowfieldLGasconPGellerMDigital health for optimal supportive care in oncology: benefits, limits, and future perspectives20202845891210.1007/s00520-020-05539-1Open DOISearch in Google Scholar